Analyst consensus rating

BioVie Analyst Rating: none

Direct answer

BioVie's consensus rating is none.

2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.26.
Forecast evidence checked November 17, 2026.

Get free BioVie email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.08
Average price target
$5.26
High price target
$5.51
Low price target
$5.00
Low target gap
+363%
Target upside
+386.6%
High target gap
+410.2%
Target range width
47.2%
Consensus rating
none
Analysts
2
Evidence date
November 17, 2026
Valid through
November 24, 2026

Read the frequently asked questions.

What is the analyst consensus rating for BioVie?

BioVie has a verified none consensus. The same dataset has an average price target of $5.26.

How far are BioVie's low and high targets from the recorded price?

The low target implies +363%, while the high target implies +410.2%.

How many analysts are included in BioVie's consensus?

The verified consensus includes 2 analysts.

How is BioVie's target upside or downside calculated?

The average target of $5.26 is divided by the recorded price of $1.08, then one is subtracted to produce +386.6%. This does not guarantee a future return.

When was BioVie's analyst forecast verified?

The data was verified on 2026-11-17. The dataset is valid through 2026-11-24.